Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Hirsutism requires identifying the cause to choose the right treatment, which may include medications like oral contraceptives or dexamethasone.

Skin symptoms like fragile skin and easy bruising can indicate Cushing's syndrome, which requires early diagnosis and treatment to prevent serious health issues.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Patterned hair loss in women is linked to hormonal imbalances and biochemical changes, and should be evaluated for underlying health issues.

Hair growth pathways are a promising and simpler method for detecting chronic stress.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Hormones and iron deficiency are linked to female pattern hair loss, and hair thinning patterns are similar across different types of this condition.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

The conclusion is that hirsutism is strongly linked to PCOS and higher levels of certain hormones, but not to DHEAS, prolactin, cortisol, or TSH.

Higher testosterone and DHEA-S levels may be linked to male pattern baldness.

Different hair loss patterns may be linked to varying male hormone levels.